Golimumab for rheumatoid arthritis
24 results
1 - 24
Golimumab for rheumatoid arthritis 
Golimumab for rheumatoid arthritis: Cochrane systematic review- Rheumatoid arthritis
- Biologics for people with rheumatoid arthritis naive to methotrexate
- Biologic interventions for fatigue in rheumatoid arthritis
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics
- Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Chronic diseases and pregnancy
Biologicals improve outcomes in patients with RA- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview